FDA Approves Alzheimer's Drug for the First Time Since 2003

For more on the new Alzheimer’s drug and what it could mean, The Takeaway spoke to Jennifer Manly, a professor at the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain at Columbia University, and Pam Belluck, health and science writer at the New York Times. [listen]

Source: WNYC Radio: The Takeaway